Dr. Chad M. Domangue, MD

Dr. Domangue practices at Neuroscience & Pain Institute in Hammond, Louisiana.

Dr. Domangue's NPI, 1629286646, was assigned on May 21, 2007. Dr. Domangue graduated from LSU Health Shreveport School of Medicine in 2003. Dr. Domangue's Louisiana license number on file is 202018.

Dr. Domangue's primary practice is Neuroscience & Pain Institute, at 19065 Dr John Lambert Dr, Hammond, LA 70403 in Tangipahoa Parish. The practice phone is (985) 991-4457.

Dr. Domangue's primary practice is Neuroscience & Pain Institute in Hammond, Louisiana. Dr. Domangue is also affiliated with North Oaks Medical Center. The medical group on file is Neuroscience & Pain Institute. Dmand AI also links Dr. Domangue to 1 more hospital, 2 group practices and clinics, 1 physician office and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Domangue practices, 5 sites in all. Vendor and product names are available with a free account.

Interventional pain medicine is Dr. Domangue's primary specialty in the NPI Registry, under taxonomy code 208VP0014X. Dr. Domangue is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Domangue's licenses on file in 5 states: Louisiana, Mississippi, Kentucky, Virginia and South Carolina.

Dmand AI lists back pain injection, lower back pain, muscle pain, fibromyalgia, and limb pain, neck pain and spine problems, spinal stenosis and thoracic spine disorders among the conditions Dr. Domangue treats.

CMS data shows 366 Medicare services from Dr. Domangue across 7 procedure codes in 2024, for 101 Medicare patients. Medicare paid $22,239 for them.

CMS counts 101 Medicare patients who saw Dr. Domangue in 2024. The largest group is 65 to 74, with 53 patients. 75% of them have arthritis, and 75% have high blood pressure. 23% are also on Medicaid. Their average risk score is 1.33, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Domangue's median patient age at 65, with 59% women.

In 2024, Dr. Domangue wrote 4,557 Medicare Part D claims for 516 patients. 97% of them were for generic drugs. CMS names the drug for 4,371 of them, across 32 drugs with 11 or more claims each, at $130,489 in total drug cost. In 2023, CMS named 14,273 claims across 56 drugs.

Dr. Domangue accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Domangue as offering telehealth.

Dmand AI links Dr. Domangue to 1 clinical trial. Conditions studied include Pain, Intractable and Cancer Pain. Open Payments lists research payments to Dr. Domangue that name 1 trial.

CMS Open Payments shows 141 general payments to Dr. Domangue from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 76% of the total. Boston Scientific Corporation paid the most, $2,659. It also lists 5 research payments totaling $221,450 from 2016 to 2020, naming 1 clinical trial.

Dmand AI lists 1 award for Dr. Domangue, most recently CMS Stage 1 2012 in 2011.

Dr. Domangue graduated from LSU Health Shreveport School of Medicine in 2003.

Dr. Domangue is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.